IE32170B1 - Piperidine derivative - Google Patents
Piperidine derivativeInfo
- Publication number
- IE32170B1 IE32170B1 IE637/71A IE63771A IE32170B1 IE 32170 B1 IE32170 B1 IE 32170B1 IE 637/71 A IE637/71 A IE 637/71A IE 63771 A IE63771 A IE 63771A IE 32170 B1 IE32170 B1 IE 32170B1
- Authority
- IE
- Ireland
- Prior art keywords
- piperidine
- tetrahydrofuryl
- oxo
- hydroxy
- formula
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000010438 heat treatment Methods 0.000 abstract 4
- GATQULLZZYQJBS-UHFFFAOYSA-N 3-(4-hydroxypiperidin-4-yl)oxolan-2-one Chemical compound OC1(CCNCC1)C1C(OCC1)=O GATQULLZZYQJBS-UHFFFAOYSA-N 0.000 abstract 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- LSABJPIDIAERGU-UHFFFAOYSA-N 3-(1-benzyl-4-hydroxypiperidin-4-yl)oxolan-2-one Chemical compound C1CC(O)(C2C(OCC2)=O)CCN1CC1=CC=CC=C1 LSABJPIDIAERGU-UHFFFAOYSA-N 0.000 abstract 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- -1 alkanoyl radical Chemical class 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000002990 phenothiazines Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 abstract 2
- SJZKULRDWHPHGG-UHFFFAOYSA-N 1-benzylpiperidin-4-one Chemical compound C1CC(=O)CCN1CC1=CC=CC=C1 SJZKULRDWHPHGG-UHFFFAOYSA-N 0.000 abstract 1
- HGMRAVXAXMAVSQ-UHFFFAOYSA-N 3-(2-chlorophenothiazin-10-yl)propan-1-ol Chemical compound OCCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C12 HGMRAVXAXMAVSQ-UHFFFAOYSA-N 0.000 abstract 1
- HLSLMUBMPFLBQY-UHFFFAOYSA-N 3-(2-chlorophenothiazin-10-yl)propyl ethyl carbonate Chemical compound ClC1=CC=2N(C3=CC=CC=C3SC2C=C1)CCCOC(=O)OCC HLSLMUBMPFLBQY-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 230000002908 adrenolytic effect Effects 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003610 charcoal Substances 0.000 abstract 1
- 230000000911 decarboxylating effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000012362 glacial acetic acid Substances 0.000 abstract 1
- 229940093915 gynecological organic acid Drugs 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH558967A CH497458A (de) | 1967-04-19 | 1967-04-19 | Verfahren zur Herstellung neuer Phenothiazin-Derivate |
| CH1705667 | 1967-12-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32170L IE32170L (en) | 1968-10-19 |
| IE32170B1 true IE32170B1 (en) | 1973-05-02 |
Family
ID=25698043
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE637/71A IE32170B1 (en) | 1967-04-19 | 1968-04-17 | Piperidine derivative |
| IE444/68A IE32169B1 (en) | 1967-04-19 | 1968-04-17 | Phenothiazine derivatives |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE444/68A IE32169B1 (en) | 1967-04-19 | 1968-04-17 | Phenothiazine derivatives |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3531480A (enExample) |
| AT (2) | AT293372B (enExample) |
| AU (2) | AU5480173A (enExample) |
| BE (1) | BE713802A (enExample) |
| BG (1) | BG17326A3 (enExample) |
| CH (1) | CH497458A (enExample) |
| DE (1) | DE1770218A1 (enExample) |
| ES (1) | ES352822A1 (enExample) |
| FR (1) | FR1583822A (enExample) |
| GB (2) | GB1223315A (enExample) |
| IE (2) | IE32170B1 (enExample) |
| IL (2) | IL36239A (enExample) |
| NL (1) | NL6804983A (enExample) |
| NO (1) | NO124997B (enExample) |
| OA (1) | OA03386A (enExample) |
| RO (1) | RO54395A (enExample) |
| SE (2) | SE361884B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857943A (en) * | 1969-03-27 | 1974-12-31 | May & Baker Ltd | New phenothiazine derivatives in the treatment of spasticity of muscles |
| CH511885A (de) * | 1969-07-08 | 1971-08-31 | Sandoz Ag | Verfahren zur Herstellung neuer Furanonderivate |
| US6310059B1 (en) * | 1998-06-30 | 2001-10-30 | Neuromed Technologies, Inc. | Fused ring calcium channel blockers |
| US20040259866A1 (en) * | 1998-06-30 | 2004-12-23 | Snutch Terrance P. | Calcium channel blockers comprising two benzhydril moieties |
| WO2007133481A2 (en) * | 2006-05-11 | 2007-11-22 | Neuromed Pharmaceuticals Ltd. | Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| WO2012122279A1 (en) | 2011-03-08 | 2012-09-13 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1212031A (fr) * | 1957-10-21 | 1960-03-21 | Rhone Poulenc Sa | Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation |
-
1967
- 1967-04-19 CH CH558967A patent/CH497458A/de not_active IP Right Cessation
-
1968
- 1968-03-11 GB GB40359/70A patent/GB1223315A/en not_active Expired
- 1968-03-11 GB GB01783/68A patent/GB1223314A/en not_active Expired
- 1968-04-09 NL NL6804983A patent/NL6804983A/xx unknown
- 1968-04-10 SE SE05102/71A patent/SE361884B/xx unknown
- 1968-04-10 SE SE04843/68A patent/SE356520B/xx unknown
- 1968-04-16 NO NO681425A patent/NO124997B/no unknown
- 1968-04-17 DE DE19681770218 patent/DE1770218A1/de active Pending
- 1968-04-17 ES ES352822A patent/ES352822A1/es not_active Expired
- 1968-04-17 IL IL6836239A patent/IL36239A/en unknown
- 1968-04-17 US US721949A patent/US3531480A/en not_active Expired - Lifetime
- 1968-04-17 IL IL6829842A patent/IL29842A/en unknown
- 1968-04-17 AT AT1201369A patent/AT293372B/de not_active IP Right Cessation
- 1968-04-17 BG BG9805A patent/BG17326A3/xx unknown
- 1968-04-17 BE BE713802D patent/BE713802A/xx unknown
- 1968-04-17 AT AT374668A patent/AT292726B/de not_active IP Right Cessation
- 1968-04-17 IE IE637/71A patent/IE32170B1/xx unknown
- 1968-04-17 IE IE444/68A patent/IE32169B1/xx unknown
- 1968-04-18 RO RO196856492A patent/RO54395A/ro unknown
- 1968-04-18 FR FR148511A patent/FR1583822A/fr not_active Expired
- 1968-04-19 OA OA53262A patent/OA03386A/xx unknown
-
1973
- 1973-04-19 AU AU54801/73A patent/AU5480173A/en not_active Expired
- 1973-04-19 AU AU54802/73A patent/AU5480273A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1223314A (en) | 1971-02-24 |
| NO124997B (enExample) | 1972-07-03 |
| SE361884B (enExample) | 1973-11-19 |
| IL29842A (en) | 1971-05-26 |
| IE32170L (en) | 1968-10-19 |
| AT292726B (de) | 1971-09-10 |
| US3531480A (en) | 1970-09-29 |
| DE1770218A1 (de) | 1971-10-14 |
| IE32169L (en) | 1968-10-19 |
| GB1223315A (en) | 1971-02-24 |
| BE713802A (enExample) | 1968-10-17 |
| CH497458A (de) | 1970-10-15 |
| AT293372B (de) | 1971-10-11 |
| RO54395A (enExample) | 1973-02-17 |
| ES352822A1 (es) | 1969-11-16 |
| IL36239A (en) | 1971-06-23 |
| OA03386A (fr) | 1970-12-15 |
| NL6804983A (enExample) | 1968-10-21 |
| BG17326A3 (enExample) | 1973-07-25 |
| IE32169B1 (en) | 1973-05-02 |
| IL29842A0 (en) | 1968-06-20 |
| SE356520B (enExample) | 1973-05-28 |
| AU5480173A (en) | 1973-07-12 |
| AU5480273A (en) | 1973-07-12 |
| FR1583822A (enExample) | 1969-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE40945L (en) | Benzomorphane derivatives. | |
| KR860009007A (ko) | 피페리딜리덴 디하이드로-디벤조[a,d]-사이클로헵텐의 제조방법 | |
| GB8905796D0 (en) | Composition and use | |
| GB1055055A (en) | Improvements in or relating to 4-[1-lower alkyl piperidylidene-(4)]-9,10-dihydro-4h-benzo[4,5]-cyclohepta[1,2-b]thiophene derivatives | |
| IE32169B1 (en) | Phenothiazine derivatives | |
| GB1062714A (en) | -ß-(4'-acyloxy-4'-piperidyl)-ketones | |
| KR890001950A (ko) | 4-아미노-치환된 1.2- 디하이드록시나프탈렌 유도체 | |
| GB1277789A (en) | Improvements in or relating to new polycyclic pyrrole derivatives | |
| KR840005147A (ko) | 신규 티에노-피리디논 유도체의 제조방법 | |
| GB1153670A (en) | Isoquinoline Derivatives and preparation thereof | |
| ATE29721T1 (de) | 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate. | |
| SE7416163L (enExample) | ||
| GB1499420A (en) | Ergot peptide alkaloids | |
| IE43413L (en) | Behenic acid ester | |
| GB1299201A (en) | Medicaments derived from thiazolidine carboxylic acid | |
| KR900016240A (ko) | 불포화된 아미노디카복실산 유도체 | |
| IE35323L (en) | Tropan-3-ol derivatives | |
| IE831075L (en) | Thiophene derivatives | |
| JPS56120699A (en) | 177aminoo166hydroxysteroid of novel androstane and estrane* its derivative and its drug composition | |
| GB949732A (en) | New piperidine derivatives and process for their production | |
| SE8804696D0 (sv) | Dioxazocine derivatives their preparation and compositions containing them | |
| US3627769A (en) | 1-(4,5-DIHYDROTHIENO{8 2,3-b{9 {0 {8 1{9 {0 BENZOTHIEPIN-4-YL)-PIPERAZINES | |
| GB1158530A (en) | Ergoline Derivatives | |
| GB1504683A (en) | Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives | |
| GB1410872A (en) | Tetrahydropyran and tetrahydrothiapyran derivatives |